Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06059027 · ClinicalTrials.gov registry record
Microbes and Respiratory Illnesses
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 290
- Enrollment target
NCT06059027: Completed study, sponsored by University of Wisconsin, Madison.
NCT06059027 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06059027 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
This study is called the Microbes and Respiratory Illnesses (MARI) Study. Children growing up on farms are exposed to many types of microbes that could be beneficial. It is thought that increased exposure to certain types of microbes early in life helps to develop a healthy immune system and reduce the risk for severe common cold illnesses, breathing problems, and allergies.
Primary Outcome
The primary outcome for illness severity will be the Respiratory Illness Burden Index (RIBI), which is calculated as the area under the curve (AUC) for symptom scores and days of illness, as previously described. It is calculated by summing the WURSS (cold symptoms assessment) scores for each day of respiratory illness during the observation period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2025-11-06 |
What the finished NCT06059027 record still lists
NCT06059027 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06059027 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06059027 about?
NCT06059027 is a clinical study titled "Microbes and Respiratory Illnesses". This study is called the Microbes and Respiratory Illnesses (MARI) Study. Children growing up on farms are exposed to many types of microbes that could be beneficial. It is thought that increased exposure to certain types of microbes early in life helps to develop a healthy immune system and reduce ...
What is the current status of trial NCT06059027?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2023-10-18. Estimated completion is 2025-11-06.
Who is sponsoring clinical trial NCT06059027?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI